Javed Anees: When Rheumatic Heart Disease Causes Stroke
Javed Anees, Medical Consultant at Government of Kerala, shared a post on LinkedIn:
”Embolic stroke remains one of the most devastating complications of rheumatic heart disease, yet timely recognition and evidence-based management can significantly improve outcomes.
I created this infographic to provide a concise, practical overview of the complete management pathway—from identifying the cardioembolic source and acute reperfusion strategies to anticoagulation timing, valve intervention, and long-term secondary prevention.
Key learning points:
Reperfuse eligible patients without delaying evidence-based acute stroke care.
Avoid routine urgent therapeutic heparin after acute cardioembolic ischemic stroke.
Individualize the timing of anticoagulation based on infarct size, hemorrhagic transformation, and repeat neuroimaging.
Warfarin remains the standard of care for atrial fibrillation associated with moderate-to-severe rheumatic mitral stenosis, supported by the INVICTUS trial and contemporary international guidelines.
Always consider infective endocarditis and assess the need for definitive valve intervention.
I hope this serves as a useful, high-yield learning resource for colleagues in Neurology, Internal Medicine, Cardiology, Emergency Medicine, and Critical Care.
I welcome your thoughts, feedback, and clinical experiences.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology
-
Sep 23, 2026, 13:04Ben Samelson-Jones: Do Gene Variants Drive PK Differences in FIX-Fusion and N9-GP Therapies?
-
Sep 23, 2026, 12:57Shelly Reed: Advocating for HTCs and CDC Funding with the Hemophilia Federation of America
-
Sep 23, 2026, 12:51Domenico Girelli: How Verona Hospital Transformed ED Anemia Care with Patient Blood Management